Zura Bio Limited (ZURA )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ZURA
- Company Zura Bio Limited
- Price $5.35
- Changes Percentage 17.84
- Change 0.81
- Day Low $4.47
- Day High $5.44
- Year High $7.44
- Year Low $1
- Market Cap $250,984,839
- Price Avg 50 EMA (D) $5.15
- Price Avg 200 EMA (D) $4.54
- Exchange NASDAQ
- Volume 668,790
- Average Volume 630,666
- Open $4.5
- Previous Close $4.54
- EPS -1.09
- PE -3.54
- Earnings Announcement 2026-05-07 12:30:00
- Shares Outstanding $65,021,979
Company brief: ZURA BIO LIMITED (ZURA )
- Healthcare
- Biotechnology
- Mr. Robert Lisicki
- https://zurabio.com
- US
- N/A
- 03-21-2023
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.